Robuta

https://scholars.duke.edu/publication/760968 Scholars@Duke publication: Third-generation aromatase inhibitors: Differences between the agents... third generation aromatase inhibitors differences between scholars duke https://eprints.ncl.ac.uk/290906 Systematic review of economic evaluations of aromatase inhibitors in estrogen receptor-positive... systematic review economic evaluations aromatase inhibitors estrogen receptor https://pmc.ncbi.nlm.nih.gov/articles/PMC8090375/ Aromatase Inhibitors in Erectile Dysfunction - PMC Hyperestrogenism may cause erectile dysfunction(ED) by impeding normal penile development,increasing venous vascular permeability and leakage(via VEGF) and by... aromatase inhibitors erectile dysfunction pmc https://scholars.duke.edu/publication/760983 Scholars@Duke publication: Aromatase inhibitors for breast cancer: proven efficacy across the... aromatase inhibitors https://docs.google.com/file/d/1SG3EM7mckObSiAggljPNlyJVz8hYUtsw/preview AROMATASE INHIBITORS IN MEN.pdf - Google Drive aromatase inhibitors men pdf google drive https://eprints.soton.ac.uk/488766/ Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: a... https://www.news-medical.net/health/What-are-Aromatase-Inhibitors.aspx What are Aromatase Inhibitors? Jan 20, 2023 - Aromatase inhibitors are a class of hormonal agents that form part of the therapy for some types of breast cancer. These agents are available as pills and may... aromatase inhibitors https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1529342/full Frontiers | Evaluation of dermatologic adverse events associated with aromatase inhibitors:... BackgroundThis study evaluates the risk of dermatologic adverse events (AEs) associated with aromatase inhibitors (AIs) through an analysis of data from the ... adverse events associated with frontiers evaluation dermatologic https://pubmed.ncbi.nlm.nih.gov/30014974/ Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors Moderate to severe fatigue complaints exceed 50% among AI users. Fatigue is highly related to younger age, higher education level, higher BMI, pain severity... https://www.medsci.ox.ac.uk/news/continuing-hormone-treatment-with-aromatase-inhibitors-beyond-five-years-further-reduces-the-risk-of-breast-cancer-recurrence-by-a-quarter-in-postmenopausal-women Continuing hormone treatment with aromatase inhibitors beyond five years further reduces the risk... Continuing treatment with aromatase inhibitors (a type of hormone therapy) for another five years reduces the risk of developing secondary breast cancer by... https://www.ctsu.ox.ac.uk/news/aromatase-inhibitors-are-better-than-tamoxifen-at-reducing-the-risk-of-breast-cancer-recurrence-in-premenopausal-as-well-as-postmenopausal-women?9f445592-52bc-11f1-a331-f72cba4817da Aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in...